These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 9921264)

  • 1. [Development of high-performance frontal analysis and application to drug-plasma protein binding study].
    Shibukawa A
    Yakugaku Zasshi; 1998 Dec; 118(12):554-65. PubMed ID: 9921264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-performance frontal analysis for drug-protein binding study.
    Shibukawa A; Kuroda Y; Nakagawa T
    J Pharm Biomed Anal; 1999 Jan; 18(6):1047-55. PubMed ID: 9925341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Determination of unbound concentration of drug in drug-human serum albumin mixture by high performance frontal analysis].
    Qiao MX; Guo XJ; Li FM
    Se Pu; 2001 Jul; 19(4):329-31. PubMed ID: 12545492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of the unbound concentration of hydrophobic drugs in albumin solutions by high-performance frontal analysis using a diol-silica column.
    Shibukawa A; Nakao C; Sawada T; Terakita A; Morokoshi N; Nakagawa T
    J Pharm Sci; 1994 Jun; 83(6):868-73. PubMed ID: 9120823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein-binding high-performance frontal analysis of (R)- and (S)-warfarin on HSA with and without phenylbutazone.
    He J; Shibukawa A; Tokunaga S; Nakagawa T
    J Pharm Sci; 1997 Jan; 86(1):120-5. PubMed ID: 9002471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemiluminescence detection coupled to high-performance frontal analysis for the determination of unbound concentrations of drugs in protein binding equilibrium.
    Qiao M; Guo X; Li F
    J Chromatogr A; 2002 Apr; 952(1-2):131-8. PubMed ID: 12064525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of the enantioselective binding between BOF-4272 and serum albumins by means of high-performance frontal analysis.
    Shibukawa A; Kadohara M; He JY; Nishimura M; Naito S; Nakagawa T
    J Chromatogr A; 1995 Mar; 694(1):81-9. PubMed ID: 7719472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-performance frontal analysis-high-performance liquid chromatographic system for stereoselective determination of unbound ketoprofen enantiomers in plasma after direct sample injection.
    Shibukawa A; Terakita A; He JY; Nakagawa T
    J Pharm Sci; 1992 Jul; 81(7):710-5. PubMed ID: 1403710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enantioselective protein binding of semotiadil and levosemotiadil determined by high-performance frontal analysis.
    Rodriguez Rosas ME; Shibukawa A; Ueda K; Nakagawa T
    J Pharm Biomed Anal; 1997 Jun; 15(9-10):1595-601. PubMed ID: 9226594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Theoretical study of high-performance frontal analysis:  a chromatographic method for determination of drug-protein interaction.
    Shibukawa A; Nakagawa T
    Anal Chem; 1996 Feb; 68(3):447-54. PubMed ID: 21619083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-performance capillary electrophoresis/frontal analysis for the study of protein binding of a basic drug.
    Shibukawa A; Yoshimoto Y; Ohara T; Nakagawa T
    J Pharm Sci; 1994 May; 83(5):616-9. PubMed ID: 8071806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-performance frontal analysis for the study of protein binding of troglitazone (CS-045) in albumin solution and in human plasma.
    Shibukawa A; Sawada T; Nakao C; Izumi T; Nakagawa T
    J Chromatogr A; 1995 Apr; 697(1-2):337-43. PubMed ID: 7780577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frontal analysis of drug-plasma lipoprotein binding using capillary electrophoresis.
    Ohnishi T; Mohamed NA; Shibukawa A; Kuroda Y; Nakagawa T; El Gizawy S; Askal HF; El Kommos ME
    J Pharm Biomed Anal; 2002 Jan; 27(3-4):607-14. PubMed ID: 11755761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Capillary electrophoresis/frontal analysis for microanalysis of enantioselective protein binding of a basic drug.
    Ohara T; Shibukawa A; Nakagawa T
    Anal Chem; 1995 Oct; 67(19):3520-5. PubMed ID: 8686900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous determination of unbound thyroid hormones in human plasma using high performance frontal analysis with electrochemical detection.
    Kimura T; Nakanishi K; Nakagawa T; Shibukawa A; Matsuzaki K
    J Pharm Biomed Anal; 2005 Jun; 38(2):204-9. PubMed ID: 15925209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma protein binding study of oxybutynin by high-performance frontal analysis.
    Shibukawa A; Ishizawa N; Kimura T; Sakamoto Y; Ogita K; Matsuo Y; Kuroda Y; Matayatsu C; Nakagawa T; Wainer IW
    J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Feb; 768(1):177-88. PubMed ID: 11939551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of unbound drug concentration and protein-drug binding fraction in plasma.
    Liu Z; Li F; Huang Y
    Biomed Chromatogr; 1999 Jun; 13(4):262-6. PubMed ID: 10416057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single run measurements of drug-protein binding by high-performance frontal analysis capillary electrophoresis and mass spectrometry.
    Wan H; Ostlund A; Jönsson S; Lindberg W
    Rapid Commun Mass Spectrom; 2005; 19(12):1603-10. PubMed ID: 15915447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Advances in chromatography in the study of drug-plasma protein interactions].
    Bai Y; Fan Y; Ge G; Wang F
    Se Pu; 2021 Oct; 39(10):1077-1085. PubMed ID: 34505429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific determination of unbound oxacillin in protein solution with cefoperazone by high-performance frontal analysis with chemiluminescence detection.
    Li F; Qiao M; Guo X
    Biomed Chromatogr; 2003 Jan; 17(1):53-7. PubMed ID: 12583007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.